EUZ Eckert & Ziegler Strahlen- und Medizintechnik AG

EQS-News: Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register

EQS-News: Eckert & Ziegler SE / Key word(s): Miscellaneous
Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register

02.10.2024 / 11:43 CET/CEST
The issuer is solely responsible for the content of this announcement.

Berlin, 2 October 2024. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenburg (Berlin) District Court today. With the entry in the commercial register of Eckert & Ziegler SE, the spin-off of Pentixapharm AG became legally effective. All shares in Pentixapharm AG held by Eckert & Ziegler have thus been legally transferred from Eckert & Ziegler SE to Pentixapharm Holding AG.

In compensation, the shareholders of Eckert & Ziegler SE will receive Pentixapharm Holding AG shares at a ratio of 1:1. The number of Eckert & Ziegler shares held by each Eckert & Ziegler shareholder after the close of trading today, taking into account any outstanding stock market transactions, will determine their entitlement. All Pentixapharm Holding AG shares created as part of the spin-off are expected to be admitted to the Regulated Market of the Frankfurt Stock Exchange in the Prime Standard segment on 2 October 2024.

Initial trading of the Pentixapharm Holding AG shares is scheduled for 3 October 2024. On the same day, the listing of the Eckert & Ziegler SE shares ‘ex spin-off’ is planned. The deposit-side posting of the Pentixapharm Holding shares to the securities accounts of Eckert & Ziegler shareholders is expected to take place on 7 October 2024.

Further information on the IPO of Pentixapharm AG can be found here:

About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.

Contact:
Eckert & Ziegler SE, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, ,  


02.10.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com
Language: English
Company: Eckert & Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 38
Fax:
Internet:
ISIN: DE0005659700
WKN: 565970
Indices: SDAX, TecDax,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2000709

 
End of News EQS News Service

2000709  02.10.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2000709&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
02/10/2024

Underlying

EUZEckert & Ziegler Strahlen- und Medizintechnik AG

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Eckert & Ziegler Strahlen- und Medizintechnik AG

 PRESS RELEASE
Free
EUZ Eckert & Ziegle...

EQS-News: Eckert & Ziegler und GlyTherix unterzeichnen Vertrag zur Lie...

EQS-News: Eckert & Ziegler SE / Schlagwort(e): Vertrag/Kooperation Eckert & Ziegler und GlyTherix unterzeichnen Vertrag zur Lieferung von Lutetium-177 08.10.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, Deutschland und Sydney, Australien - 08. Oktober 2024 - Eckert & Ziegler (ISIN DE0005659700, SDAX) und GlyTherix Ltd (GlyTherix), ein australisches Unternehmen aus dem Bereich der zielgerichteten Strahlentherapie, das sich auf die Entwicklung von Antikörper-Radiopharmaka zur Behandlung von soliden Tumoren spezial...

8h / 42m 1 DE
 PRESS RELEASE
Free
EUZ Eckert & Ziegle...

EQS-News: Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-1...

EQS-News: Eckert & Ziegler SE / Key word(s): Contract/Alliance Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply 08.10.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, Germany and Sydney, Australia - 08. October 2024  - Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced a new global clinical supply agreement. Eckert & Ziegler will provide its GM...

8h / 42m 1 EN
 PRESS RELEASE
Free
EUZ Eckert & Ziegle...

EQS-News: Eckert & Ziegler: Abspaltung der Pentixapharm AG im Handelsr...

EQS-News: Eckert & Ziegler SE / Schlagwort(e): Sonstiges Eckert & Ziegler: Abspaltung der Pentixapharm AG im Handelsregister eingetragen 02.10.2024 / 11:43 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, 2.10.2024. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) informiert, dass der in der ordentlichen Hauptversammlung vom 26.6.2024 beschlossene Abspaltungsbeschluss am heutigen Tag in das Handelsregister des Amtsgerichts Charlottenburg (Berlin) eingetragen wurde. Mit der Eintragung in das Handelsregister der Eckert & Ziegl...

October 2, 2024 1 DE
 PRESS RELEASE
Free
EUZ Eckert & Ziegle...

EQS-News: Eckert & Ziegler: Spin-off of Pentixapharm AG Registered wit...

EQS-News: Eckert & Ziegler SE / Key word(s): Miscellaneous Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register 02.10.2024 / 11:43 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, 2 October 2024. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenburg (Berlin) District Court today. With the entry in the commercial register of Eckert & Ziegler SE, the spin-o...

October 2, 2024 1 EN
 PRESS RELEASE
Free
EUZ Eckert & Ziegle...

EQS-News: Eckert & Ziegler opens new facilities for radiopharmaceutica...

EQS-News: Eckert & Ziegler SE / Key word(s): Expansion/Miscellaneous Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden 20.08.2024 / 17:00 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, 20.08.2024. In the presence of the Saxon State Ministers Martin Dulig and Thomas Schmidt as well as the Mayor of Dresden Dirk Hilbert, the medical technology company Eckert & Ziegler today inaugurated its new 1,700 square meter facilities in Dresden with around 200 guests. The Dresden-Rossendorf site produces ...

August 20, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch